Can a new pill drain stubborn kidney swelling?
NCT ID NCT06670534
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This trial tests an experimental drug called JMKX003142 in people with kidney-related swelling (edema) that doesn't improve with standard diuretics. Participants take the drug or a placebo once daily for seven days. The study measures changes in body weight, urine output, and leg swelling to see if the drug helps remove excess fluid.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JMKX003142 tablets
- What this could lead to
- If effective, this could offer a new treatment option for kidney-related swelling that doesn't respond to standard diuretics.
- What could go wrong
- This is an early-phase trial, so the drug may not prove effective or safe. It's also a short-term study, so long-term benefits and risks are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EDEMA LEG are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Affiliated Zhongshan Hospital
Shanghai, 200102, China
-
Zhejiang Hangyu Pharmaceutical Co., Ltd（subsidiary of Jemincare）
Shanghai, 200102, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.